Health & Medicine

STAT+: Pharmalittle: We're reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more

32 sec read0 views0 listens

President Trump's initiative to make GLP-1 weight loss drugs accessible through Medicaid for low-income Americans is faltering, with only Indiana participating and other states either ending or considering ending coverage due to budget constraints. Additionally, the Trump administration plans to use a new approach to deny Medicaid coverage for gender-affirming care, which could set a precedent affecting coverage of other medications.

This development impacts healthcare access and financial sustainability in state Medicaid programs, potentially limiting coverage for essential treatments.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Real Estate & Home8 hours ago22 sec read

JLL: Planning approved for West Lothian industrial and logistics scheme and Major Industrial Deal Completed in Scotland's Central Belt

West Lothian Council has granted planning permission for a 55,500 sq m industrial and logistics development at Arches Business Park in Broxburn. This approval is crucial as it addresses the shortage of modern, high-quality space needed by businesses ...

Ali Nemati

Startups & VC8 hours ago21 sec read

Startups Are Still Acquiring Startups, Led By Ultra-High-Valuation Unicorns

Startups are increasingly acquiring other startups, particularly those backed by ultra-high-valuation unicorns like OpenAI and Databricks. This trend is driven by the need for rapid technology development and talent acquisition in competitive sectors...

Ali Nemati

Health & Medicine12 hours ago30 sec read

Episode 1159: How early should you start vasopressin after the norepinephrine infusion rate reaches 0.25 μg/kg/min or higher?

A study found that initiating vasopressin within 0-3 hours after norepinephrine reaches 0.25 μg/kg/min in septic shock patients is associated with lower 28-day mortality compared to initiating it between 3-6 hours. This 'ultra-early' strategy also co...

Ali Nemati